观点制药

The world will need to stop piggybacking on US pharma
世界不能一味依赖美国药企

Medicare’s negotiations on the cost of medicines could affect how drug research is funded globally
其他国家一直在从美国的医药创新中受益,如今,拜登政府计划对10种最畅销药品实施严厉的价格管制,此举可能影响药品研发。

When it comes to drug spending, there is one 500lb gorilla in the room: America. The US market has long been the heavyweight player — Americans shelled out more than $600bn on medicines last year, almost half the global total.The country also dominates the research pipeline; its research and development spending accounts for nearly two-thirds of the OECD total. Last year, the US had 10,265 drugs in the works, more than double both China and the EU, and four times as many as the UK.

当谈到药品支出时,房间里有一只500磅重的大猩猩——美国。美国市场长期以来一直是重量级玩家,美国人去年在药品上掏的钱超过6000亿美元,几乎占manbetx app苹果 总额的一半。

您已阅读8%(565字),剩余92%(6121字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×